Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

JAMA - Journal of the American Medical Association - United States
doi 10.1001/jama.2019.0709
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Genetic Association of Peptidoglycan Recognition Protein Variants With Inflammatory Bowel Disease

PLoS ONE
Multidisciplinary
2013English

Editorial: Thiopurine-Induced Myelosuppression and Infections in Inflammatory Bowel Disease Patients With a Normal TPMT Genotype-The Perils of Ageing. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Thiopurine Metabolites and the Role of Thiopurine Methyltransferase Activity in Inflammatory Bowel Disease

Gut
Gastroenterology
2002English

Pain Management in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2014English

Ophthalmologic Manifestations in Patients With Inflammatory Bowel Disease

Intestinal Research
Gastroenterology
2017English

Psychiatric Illness in Patients With Inflammatory Bowel Disease.

Gut
Gastroenterology
1987English

Myelosuppression Monitoring After Immunomodulator Initiation in Veterans With Inflammatory Bowel Disease: A National Practice Audit

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2012English

MYO9B Polymorphisms in Patients With Inflammatory Bowel Disease

Gut
Gastroenterology
2007English

Association Between Overlapping Syndromes and Renal Lithiasis in Patients With Inflammatory Bowel Disease

Acta Scientific Gastrointestinal Disorders
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy